Perfil
Guy Chatelain is currently a Director at EUSA Pharma SAS, Indufina, Industrielle et Financière Holding Genève SA, Cellmark SA, Ms Medical Synergy SA, a Member of the Swiss Bar Association, Geneva Association of Business Law, and Geneva Bar Association.
He was previously the President & Managing Director at Seventure Partners SA, a Director at Orphan Synergy Europe-Pharma SA, and a Director at OSE Immunotherapeutics SA from 2012 to 2018.
He was also a Principal at Pestalozzi Lachenal Patry from 1977 to 1984 and a Partner & Attorney at Law at Mentha & Associés.
Mr. Chatelain holds an MBA from École des Hautes Études Commerciales de Paris.
Cargos activos de Guy Chatelain
| Empresas | Cargo | Inicio |
|---|---|---|
EUSA Pharma SAS
EUSA Pharma SAS BiotechnologyHealth Technology Specializes in pharmaceutical research for rare diseases | Director/Miembro de la Junta | - |
Ms Medical Synergy SA
Ms Medical Synergy SA Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Director/Miembro de la Junta | - |
Cellmark SA
Cellmark SA Wholesale DistributorsDistribution Services Wholesales cellulose and paper products | Director/Miembro de la Junta | - |
Indufina, Industrielle et Financière Holding Genève SA | Director/Miembro de la Junta | - |
Geneva Bar Association | Corporate Officer/Principal | - |
Swiss Bar Association
Swiss Bar Association Swiss Bar Association is a company. 'The company is based in Bern, Switzerland. | Corporate Officer/Principal | - |
Geneva Association of Business Law | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Guy Chatelain.
| Empresas | Cargo | Fin |
|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Director/Miembro de la Junta | 03/01/2018 |
Seventure Partners SA
Seventure Partners SA Investment ManagersFinance Seventure Partners invests in companies located in Israel, Asia and North America primarily in Europe. The firm focuses on digital technologies and life sciences sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of EUR 0.5 - 20 million. | Director Ejecutivo | 01/01/2013 |
| ░░░░░░░░░░ ░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | - |
Formación de Guy Chatelain.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 13 |
|---|---|
Pestalozzi Lachenal Patry
Pestalozzi Lachenal Patry Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Seventure Partners SA
Seventure Partners SA Investment ManagersFinance Seventure Partners invests in companies located in Israel, Asia and North America primarily in Europe. The firm focuses on digital technologies and life sciences sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of EUR 0.5 - 20 million. | Finance |
École des Hautes Études Commerciales de Paris
École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mentha & Associés
Mentha & Associés Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
EUSA Pharma SAS
EUSA Pharma SAS BiotechnologyHealth Technology Specializes in pharmaceutical research for rare diseases | Health Technology |
Swiss Bar Association
Swiss Bar Association Swiss Bar Association is a company. 'The company is based in Bern, Switzerland. | |
Geneva Association of Business Law | |
Geneva Bar Association | |
Indufina, Industrielle et Financière Holding Genève SA | |
Cellmark SA
Cellmark SA Wholesale DistributorsDistribution Services Wholesales cellulose and paper products | Distribution Services |
Orphan Synergy Europe-Pharma SA
Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
Ms Medical Synergy SA
Ms Medical Synergy SA Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
OSE Immunotherapeutics SA
OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
- Bolsa de valores
- Insiders
- Guy Chatelain
















